CLINICAL AND PARA CLINICAL FEATURES IN CHILDREN WITH GROWTH HORMONE DEFICIENCY (GH) AT SAINT PAUL HOSPITAL

Ngô Thị Thu Hương1,, Nguyễn Thị Thảo1, Đinh Thị Ngọc Mai1
1 Saint Paul Hospital

Main Article Content

Abstract

Background: Growth hormone (GH- somatropin) is peptide hormone secreted by the anterior lobe of the pituitary gland. It stimulates the growth of the body, height and weight in children. Growth hormone deficiency is a rare disorder disease. It results in growth retardation, short stature and maturation delays reflected by the delay of lengthening of the bones... Children need to be detected and treated early to improve their final height and help them confidently integrate into life. Objective: To analyze and describe clinical, para clinical features in children with growth hormone deficiency (GH) at Saint Paul Hospital. Research subjects: 47 children who meet the criteria for diagnosis of GH deficiency are being treated as outpatients at Saint Paul l Hospital. Research method: Case-series study. Results: 100% short stature. Facial abnormalities, typically caused by pituitary defects: 19/47. Boy with small penis and small testicular: 12/31. 100% of children have bone age lower than actual age < -2SD, mean value: 2,61 ± 2.2 years. MRI of the head is 82,9% normal. GH stimulation test showed that 93.6% of children had a complete deficiency of GH hormone, 6,4% of children with moderate growth deficiency. Conclusion: Children with slow growth rate, stunting, short stature combined with GH stimulation test (+), bone age lower than actual age are the criteria to diagnose children with GH hormone deficiency.

Article Details

References

1. Stephen Kemp 2006. Growth Hormon Deficiency. Emedicine.com. Last update: April 19.
2. Molitch .M.E 2011. Growth hormon treatment in adults with growth hormone deficiency: The transition. J Endocrin. Invest. 34. 150-154.
3. AACE. 2003. American association of clinical endocrinologists medical guidelinesforclinical prctice for growh hormon use in adults and children. Update. Endocrine practice vol 9 No.1.
4. Takeda A, Cooper K, Bird A et al. 2010. Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation. Health technol Assess Winch Engl, 14 (42), 1- 209
5. Bộ y tế. Hướng dẫn chẩn đoán và điều trị một số bệnh thường gặp ở trẻ em. 2015. Nhà xuất bản y học. 654-660
6. Rhie. YJ et al. 2019. Long- term safety and effectiveness of growth hormone therapy in Korean children with growth disorders:5- year results of LG growth study. Plos One. 14 (5) 927- 938
7. Nguyễn Thị Hằng. 2019. Nhận xét kết quả điều trị liệu pháp hormon tái tổ hợp ở bệnh nhân thiếu hụt hormon tăng trưởng tại bệnh viện Nhi trung ương. Luận văn tốt nghiệp nội trú. Trường ĐH Y Hà Nội
8. Chatelain P et al . 2017. A randomized Phase 2 Study of Long – Acting Transcon GH and daily GH in childhood GH deficiency . J Clin Endocrin, 102 (5) 1673- 1682.
9. Hou L et al. 2009. Efficacy and safety of recombinant human growth horrmone solution in children with growth hormone deficiency in China: a multicenter trial. Zhonghua Er Ke Za Zhi Chin J Pedia, 47 (1) 48-52.